1. Introduction
===============

Thyroid cancer is the most frequent malignancy of the endocrine system and its incidence is increasing worldwide.^\[[@R1]\]^ Papillary thyroid carcinoma (PTC) is the most prevalent type, accounting for about 80% of the cases in thyroid cancer. Conventional therapies for well-differentiated thyroid cancer include surgical resection, radioactive iodine, and thyroid hormone suppression therapy.^\[[@R2]\]^ Although outcomes for patients with differentiated thyroid cancer are excellent in comparison with other human cancers, advanced thyroid cancer patients such as those with radioiodine-refractory and metastatic differentiated thyroid cancer or anaplastic thyroid cancer still lack effective treatment options. Therefore, searching for an efficient method or agent is a requirement for the therapy of the cancer.

Curcumin (diferuloylmethane), a major active component of turmeric (*Curcuma longa*), is a natural polyphenolic compound. A large number of previous studies demonstrated that curcumin has anti-proliferative, antioxidant, anti-inflammatory, apoptosis-inducing, and anti-tumor properties in various cancer types.^\[[@R3]\]^ Moreover, it has been reported that curcumin is involved in the regulation of endoplasmic reticulum (ER) stress in certain cells. However, the role of curcumin participating in ER stress regulation appears to be highly cell type and context dependent. Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance.^\[[@R4]\]^ However, in human colon cancer cells, *bis*-Dehydroxy-curcumin, a curcumin derivative, activates ER stress to induce cell death.^\[[@R5]\]^ Another study has shown that curcumin induced apoptotic cell death via increasing ER stress and mitochondrial dysfunction in CD4+ T cells.^\[[@R6]\]^ Besides, the potential benefits of targeting the endoplasmic reticulum unfolded protein response (ER-UPR) as a therapeutic strategy for thyroid cancer therapy is also explored. HNHA, a dominant HDAC inhibitor, caused apoptosis of thyroid cancer cells both in vitro and in vivo owing to its induction of ER stress.^\[[@R7]\]^ Prior results in our laboratory confirmed that curcumin inhibited cell growth and induced the ER stress in the papillary thyroid carcinoma cells via activating the activating transcription factor 6 (ATF6)/X-box binding protein1 (XBP-1) pathway.^\[[@R8]\]^ Nevertheless, to our knowledge, the underlying mechanism of the anticancer effect of curcumin on thyroid cancer cells needs to be further investigated.

ER stress is a common feature of several physiological and pathological conditions affecting the function of the protein secretory pathway. Under ER stress, the unfolded protein response (UPR), an adaptive response, was activated to reduce the misfolded or unfolded protein load. However, under irreversible ER stress, UPR shifts its signaling toward cell death by activating complex pro-apoptotic programs.^\[[@R9]\]^ The mammalian UPR activates 3 principal signal transducers, RNA-like ER kinase (PERK), inositol-requiring enzyme 1α (IRE1α), and ATF6. Under ER stress, PERK undergoes oligomerization and autophosphorylation and then induces eukaryotic initiation factor 2α (eIF2α) phosphorylation causing translational arrest. Phosphorylated eIF2α allows the selective translation of activating transcription factor 4 (ATF4). ATF4 induces C/EBP homologous protein 10 (CHOP) that in turn upregulates the expression of several pro-apoptotic proteins such as growth arrest and DNA damage protein 34 (GADD34), endoplasmic oxidoreductin 1 like protein (ERO1α), and BH3-only proteins, including Bcl-2-like Protein 11 (BIM), Bcl-2 binding component 3 (PUMA) and Phorbol-12-myristate-13-acetate-induced protein 1 (NOXA).^\[[@R10]\]^ The most conserved branch of the UPR is mediated by IRE1, which is activated by autophosphorylation. Active IRE1 with endoribonuclease activity processes the mRNA encoding for X-box binding protein1 (XBP-1), producing an active transcription factor termed XBP1s. XBP1s induces the transcription of genes implicated in protein folding and quality control. ATF6 translocates to the Golgi where it is cleaved by the proteases, releasing a transcription factor that modulates the expression of chaperones and enzymes required for ER function.^\[[@R11]\]^

ER contains high concentration of Ca^2+^. It has been reported that a substantial burst of intracellular Ca^2+^ release was the primary event that triggered cell apoptosis.^\[[@R12]\]^ Excessive Ca^2+^ accumulation in the mitochondrial matrix causes mitochondrial swelling, the dissipation of the mitochondrial membrane potential (ΔΨm), production of mitochondrial reactive oxygen species (ROS), rupture of the outer mitochondrial membrane, and subsequent release of cytochrome *c* (Cyt *c*).^\[[@R13]\]^

In the present study, we showed that curcumin induced ER stress in BCPAP cells characterized by the activation of IRE1-XBP1 axis and ATF6-CHOP pathway. Our results also provide evidences for the SERCA2-Ca^2+^-CaMKII-JNK pathway as a central mechanism of curcumin-induced intracellular Ca^2+^ homeostasis disruption and apoptosis in human papillary thyroid carcinoma BCPAP cells.

2. Materials and methods
========================

Ethical approval was not necessary because no patients' information was collected according to Ethics Committee of Jiangsu Institute of Nuclear Medicine.

2.1. Reagents and chemicals
---------------------------

Curcumin (catalog No. C7727, purity ≥94%), 4-phenylbutyrate (4-PBA, purity \>98%), Hoechst 33342, Rhodamine 123 were all purchased from Sigma--Aldrich (St Louis, MO). Propidium iodide (PI) was purchased from Enzo Life Sciences (Farmingdale, NY). DMSO (dimethyl sulfoxide) and MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) were purchased from Sangon (Shanghai, China). SP600125 and Lipo 6000 were purchased from Beyotime Institute of Biotechnology (Kumamoto, Japan). Rhod-2/AM was purchased from Dojindo Molecular Technologies. ER-Tracker was purchased from Beyotime Biotechnology (China). 1,2-bis (2-aminophenoxy) ethane N,N,N′,N′-tetraacetic acid acetoxymethyl ester (BAPTA-AM) was purchased from Adooq Bioscience (Irvine, CA). Low melting point agarose was purchased from Takara (QingDao, China). Annexin V-FITC/PI apoptosis detection kit was purchased from BD Biosciences (San Jose, CA). Ca^2+^-ATPase kit was provided by Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The antibodies used were as follows: anti-ATF6 (sc-22799), anti-XBP-1 (sc-7160), anti-CaMKII (sc-9035), anti-CHOP (sc-7351), anti-PARP (sc-7150), anti-β-actin (sc-47778), and goat anti-mouse (sc-2005), or rabbit (sc-2004) IgG-HRP were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-SERCA2 (cst-9580), anti-p-JNK (T183/Y185, cst-4668), anti-Bax (cst-2772), anti-Bid (cst-2002), anti-caspase-8 (cst-9746), anti-caspase-7 (cst-9492), and anti-caspase-3 (cst-9665) were purchased from Cell Signaling Technology (Beverly, MA). Anti-p-CaMKII (T286, \#3891) was purchased from EPITOMICS. Anti-p-IRE1α (Ser724, NB100-2323) was purchased from Novus Biologicals (Littleton, CO). Anti-IRE1α (A1601), anti-JNK (AJ518-1), anti-Bcl-2 (AB126-1), and anti-Bcl-X~L~ (AB112-1) were purchased from Beyotime Institute of Biotechnology. Other chemicals were analytical grade and purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).

2.2. Cell culture
-----------------

BCPAP cells were obtained from the German Collection of Micro-organisms and Cell Cultures (Braunschweig, Germany) and maintained in a complete RPMI 1640 medium (Gibco, NY) with 10% calf serum (CS; Sijiqing, Hangzhou, China), 100 U/mL penicillin, and 100 U/mL streptomycin. Cells were cultured in a humid atmosphere (5% CO~2~, 37 °C).

2.3. Drug treatments
--------------------

Curcumin was dissolved in DMSO to yield 50 mM stock solutions and stored frozen until use. Unless mentioned otherwise, BCPAP cells were treated with different concentrations of curcumin (12.5--50 μM) for 24 hours. DMSO was used as the solvent control (SC). BAPTA-AM was stored in DMSO at 40 mM and diluted to a final concentration of 0.01 to 10 μM for use. To be pointed out, the final DMSO concentration did not exceed 0.1% (v/v) in any experiment. 4-PBA was directly dissolved in culture medium at a concentration of 2.5 to 10 mM when used.

2.4. Soft agar colony formation assay
-------------------------------------

For analysis of anchorage-independent cell growth in vitro, soft agar colony formation assay was performed using a 2-layer soft agar system as described previously with some modifications.^\[[@R14]\]^ Briefly, BCPAP cells pretreated with different dosages of curcumin for 6 hours were seeded into a 24-well agar plates containing an agar base layer. The cells (1 × 10^4^ cells per well) suspended in 0.6 mL of top agar (0.6% low melting point agarose in 2 × RPMI 1640 complete cell culture medium) were overlaid onto a layer of 0.6 mL of bottom agar (1.2% low melting point agarose in the same culture medium). After 14 days incubation, the colonies were stained with 0.02% (w/v) crystal violet. The images were captured with the GIS-2019 system (Tanon, Shanghai, China) and the relative colony formation ability was calculated.

2.5. Measurement of mitochondrial membrane potential
----------------------------------------------------

Mitochondrial membrane was monitored using the fluorescent dye Rhodamine 123, which preferentially partitions into active mitochondria based on the highly negative mitochondrial membrane potential.^\[[@R15]\]^ Depolarization of mitochondrial membrane potential results in the loss of Rhodamine 123 from the mitochondria and a decrease in intracellular fluorescence. After cultured cells were treated as indicated, cells were probed with Rhodamine 123 (10 μM) for 15 minutes at 37 °C and then washed twice with PBS for immediate detection. Fluorescence of 10,000 cells per sample was determined by flow cytometry (FACSCalibur, Becton Dickinson, CA) using the FL1 channel.

2.6. Cell apoptosis assay
-------------------------

For analysis of apoptosis, cells exposed to different dosages of curcumin for 24 hours were harvested. The cell pellet was then washed twice with cold PBS. An Annexin V-FITC and PI apoptosis detection kit (BD Biosciences) was used according to the manufacturer\'s directions. Briefly, cells were resuspended at 1 × 10^6^ cells/mL in 100 μL of binding buffer. Annexin V-FITC (5 μL) and 10 μL of PI (20 μg/mL) were added to the cell suspension followed by incubation at room temperature for 15 minutes in the dark and then mixed with 400 μL of binding buffer. A total of 1 × 10^4^ cells/sample was analyzed on the FACSCalibur.

2.7. Measurement of ER size
---------------------------

Cultured cells were treated as indicated and the medium was removed from the culture dish. Then cells were rinsed with PBS, added ER-Tracker staining solution (1 μM) and incubated for 20 minutes at 37 °C. The cells were then pelleted by centrifugation and resuspended in PBS for flow cytometry analysis.

2.8. Hoechst 33342/PI staining assay
------------------------------------

BCPAP cells were seeded in 96-well plates at a density of 1 × 10^4^ cells/well and cultured overnight. Then the cells were pretreated with or without 4-PBA (10 mM) for 1 hour followed by curcumin (50 μM) treatment for additional 24 hours. After incubation, the cells were stained with a combination of Hoechst 33342 (10 μg/mL) and PI (10 μg/mL) at 37 °C for 15 minutes. The cell images were captured using a fluorescence microscope (Olympus, X51, Japan). Cell were counted for five independent microscopic fields per well. Cell death rate (%) = (PI-positive staining cell number/total cell number) × 100%.

2.9. Western blotting
---------------------

After BCPAP cells were exposed to different treatments, cells were collected and washed with PBS. The whole cell proteins were extracted by ice-cold lysis buffer (50 mM Tris--HCl, pH 7.5, 150 mM NaCl, 2 mM ethylenediaminetetraacetic acid \[EDTA\], 1% (w/v) Nonidet P-40, 0.02% (w/v) sodium azide) with supplemented protease inhibitors (1 mM phenylmethylsul-fonyl fluoride, PMSF). The protein concentration was measurement by Bradford assay. Equal amounts of protein were separated by 10% or 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then electrotransferred onto a nitrocellulose membrane (Millipore). Then the membranes were incubated with the indicated primary antibodies overnight at 4 °C, followed by appropriate HRP-conjugated secondary antibody incubation for additional 1 hour. After that, the membranes were washed three times for 5 minutes with TBST (TBS containing 0.1% Tween 20). Finally, the membranes were incubated with ECL substrate solution (Beyotime Biotechnology, China) and visualized with autoradiography film.

2.10. Reverse transcriptase-polymerase chain reaction (RT-PCR)
--------------------------------------------------------------

Cells were collected after treated with curcumin, then whole cell RNA was extracted by the Trizol reagent (Life Technologies, Inc.). M-MLV reverse transcriptase and oligo(dT)~18~ primers were used to synthesized cDNA as the manufacturer\'s instructions. The primer sequences were as follows: *XBP-1* forward: 5′- CCTTGTAGTTGAGAACCAGG-3′ and *XBP-1* reverse: 5′- GGGGCTTGGTATATATGTGG-3′; *ERDJ3* forward: 5′-CCCTGATGATCCACAAGC-3′, and *ERDJ3* reverse: 5'′-ATTCGTCGCAGACCACCT-3′; *EDEM1* forward: 5′-GCCTCCTTTCTGCTCACA-3′ and *EDEM1* reverse: 5′- CACTCTGCTTTCCAACCC-3′; *SERP1* forward: 5′-ATGGTCGCCAAGCAAAGG-3′ and *SERP1* reverse: 5′- TCACATGCCCATCCTGAT-3′; *CHOP* forward: 5′-ACCAGGAAACGGAAACAG-3′ and *CHOP* reverse: 5′-TGCGTATGTGGGATTGAG-3′; *GRP78* forward: 5′-TCAGGGCAACCGCATCAC-3′ and *GRP78* reverse: 5′-CGCCACCCAGGTCAAACA-3′; *ACTIN* forward: 5′-GCCGGGACCTGACTGACTAC-3′ and *ACTIN* reverse: 5′-CGGATGTCCACGTCACACTT-3′. The PCR was performed using an initial step of denaturation at 95 °C for 5 minutes, with 30 cycles of amplification at 95 °C for 30 seconds, annealing at 55 to 60 °C (depending on the sequences of the primers) for 30 seconds, elongation at 72 °C for 30 seconds, and extension at 72 °C for 5 minutes. The PCR products were electrophoresed in 1.5% agarose gel and visualized by ethidium bromide (EB) dying. The relative expression was quantified densitometrically using the GIS-2019 system (Tanon, Shanghai, China), and calculated according to the reference bands of *Actin*.

2.11. Intracellular calcium measurement
---------------------------------------

Rhod 2-AM, a Ca^2+^-sensitive indicator, was used to detect intracellular calcium levels according to the manufacturer\'s protocol using calcium-free media. Briefly, BCPAP cells were preincubated in the presence or absence of a calcium chelating agent, BAPTA-AM, followed by curcumin treatment for 24 hours. The cells were subsequently loaded with Rhod-2/AM (5 μM) at 37 °C for 45 minutes in the dark and gently washed twice with D-hank\'s solution (calcium-free media). Rhod-2 binds cytoplasmic free calcium and emits a red fluorescence, which was analyzed by flow cytometry through FL2 channel.

2.12. Cell viability assay
--------------------------

Cell viability was assessed by the MTT assay which was performed as previously reported.^\[[@R16]\]^

2.13. Measurement of Ca^2+^-ATPase activity
-------------------------------------------

The sarco-endoplasmic reticulum ATPase (SERCA) activity was measured by a Ca^2+^-ATPase assay kit according to the manufacturer\'s protocols. Inorganic phosphate (Pi), which was generated from hydrolysis of ATP by ATPase, can be measured by a simple colorimetric reaction. Ca^2+^-ATPase activities were expressed in units of micromolar molecular inorganic phosphate produced per milligram of the extracted cell protein per hour (μM Pi/mg protein/h).

2.14. Construction and transfection of human CHOP shRNA plasmids
----------------------------------------------------------------

pSGU6/GFP/Neo was modified to express an shRNA from the U6 promoter. Briefly, an oligonucleotide was synthesized that consisted of a sequence specific 21 nucleotide stretch designed to target the *CHOP* (NM_001195053.1) followed by a 2 nt overhang, a loop sequence, and finally the reverse complement of the targeting sequence. Hind III and Bbs I cloning sites were added to facilitate directional cloning immediately downstream of the U6 promoter. The shRNA sequences directed against human *CHOP* were as follows: 5′-[GCGCATGAAGGAGAAAGAACA]{.ul}GG-3′ (shRNA-CHOP 1\#); 5′-[GAGAAAGAACAGGAGAATGAA]{.ul}AG-3′ (shRNA-CHOP 2\#); 5′-[ATGAACGGCTCAAGCAGGAAA]{.ul}TC-3′ (shRNA-CHOP 3\#). The control scrambled shRNA was constructed by the insertion of a similar structure but encoding a nonsense minigene with no homology to any known sequences in human and mouse genomes. The sequences for scramble shNC are as follows: 5′-[GTTCTCCGAACGTGTCACGT]{.ul}-3′. Cells were transfected with plasmids by Lipo 6000 transfection reagent according to the manufacturer\'s instructions.

2.15. Statistical analysis
--------------------------

All the quantifications are expressed as mean ± S.D. from at least 3 independent biological replicates. Statistical evaluations were performed with the Student *t* test when 2 value sets were compared. *P* ≤ .05 was considered as statistically significant.

3. Results
==========

3.1. Curcumin inhibits anchorage-independent growth of human papillary thyroid carcinoma BCPAP cells
----------------------------------------------------------------------------------------------------

Firstly, soft agar assays were performed to analyze the influence of curcumin on anchorage-independent growth (colony formation) of BCPAP cells. As shown in Fig. [1](#F1){ref-type="fig"}A, curcumin treatment resulted in a dose-dependent reduction of colony numbers of BCPAP cells after 14 days of culture, where \>90% decrease in colony formation was observed with curcumin at concentrations of 25 or 50 μM. These results indicate that curcumin has a potent inhibitory effect on the growth and proliferation of BCPAP cells.

![Curcumin inhibits the colony formation and induces the apoptosis of BCPAP cells. (A) Curcumin inhibits the colony formation ability of BCPAP cells in a dose-dependent manner. BCPAP cells were treated with different doses (12.5--50 μM) of curcumin, and the colony formation ability was measured by soft agar assay. (B) Curcumin decreases the mitochondrial membrane potential (MMP) of BCPAP cells. After treated by different doses (12.5--50 μM) of curcumin for 24 hours, MMP of BCPAP cells were determined by flow cytometry using Rhodamine 123 fluorescent dye. (C) Curcumin induces the apoptosis of BCPAP cells. BCPAP cells were treated with different doses (12.5--50 μM) of curcumin for 24 hours, and the apoptotic cells were determined by Annexin V-FITC/PI analysis. Percentage of living cells (lower left: Annexin V-FITC^−^/PI^−^), early apoptosis cells (lower right: Annexin V-FITC^+^/PI^−^), and late apoptosis cells (upper right: Annexin V-FITC^+^/PI^+^) were showed in the flow cytometry chart. All data shown represent the means ± S.D. of 3 independent experiments. SC =  solvent control. ∗*P* \< .05, ∗∗*P* \< .01.](medi-97-e11095-g002){#F1}

3.2. Curcumin decreases the mitochondrial membrane potential (MMP) and induces apoptosis in BCPAP cells
-------------------------------------------------------------------------------------------------------

Reduced mitochondrial membrane potential (MMP, ΔΨm) is considered as an initial and irreversible step towards apoptosis. As shown in Fig. [1](#F1){ref-type="fig"}B, when BCPAP cells were treated with different doses of curcumin (12.5--50 μM) for 24 hours, the MMP was rapidly reduced, which was detected by the weakening of the fluorescence intensity of a mitochondrial specific probe, Rhodamine 123. Compared with the solvent control group which only had 6.48 ± 0.53% cells with low MMP, at 25 and 50 μM of curcumin treatment, this percent dramatically increased up to 39.47 ± 14.05% and 97.27 ± 2.72%, respectively. To determine whether the cell death was apoptotic, BCPAP cells were stained with Annexin V-FITC/PI followed by flow cytometry analysis. As illustrated in Fig. [1](#F1){ref-type="fig"}C, within the concentrations ranging from 12.5, 25 to 50 μM, there was a significant increase in cell apoptotic rates from 33.26 ± 7.98% to 85.33 ± 8.49% and 93.31 ± 6.05%, respectively, compared with the solvent control group (10.67 ± 3.96%). These results indicate that curcumin induces cell apoptosis in BCPAP cells.

3.3. Curcumin induces ER expansion in BCPAP cells
-------------------------------------------------

Perturbations in ER function, a process named ER stress, plays a crucial role in cell apoptosis.^\[[@R17]\]^ Previous study reported that ER stress induced ER membrane expansion.^\[[@R18]\]^ In order to determine whether curcumin can induce the ER stress-related ER expansion, the ER size was measured by flow cytometry using ER-Tracker dyes. Compared with the control cells, BCPAP cells exposed to 50 μM of curcumin exhibited a significant enhanced fluorescence intensity of ER-Tracker dye from 1.03 ± 0.64% to 66.79 ± 10.56%, indicating an expansion of ER size (Fig. [2](#F2){ref-type="fig"}A). As expected, pretreatment with 4-phenylbutyrate (4-PBA), which is a chemical chaperone that alleviates ER stress, ameliorated the ER expansion induced by curcumin in BCPAP cells. Compared with that treated with 50 μM of curcumin only, the percent of cells with expansive ER size in BCPAP cells treated with a combination of 50 μM curcumin and 10 mM 4-PBA reduced from 63.46% to 46.12% (Fig. [2](#F2){ref-type="fig"}B). These results indicate that curcumin probably induces ER stress which is characterized by ER expansion. In order to further investigate whether the death of BCPAP cells is attributed to ER stress induced by curcumin, the effect of 4-PBA on curcumin-induced cell death was measured by Hoechst/PI staining. As expected, a combination with 4-PBA significantly reduced PI-positive cell numbers compared with that of curcumin treated-alone and the cell death rate of BCPAP cells was correspondingly decreased from 55.68 ± 1.83% to 43.47 ± 2.61% (Fig. [2](#F2){ref-type="fig"}C). Taken together, these data demonstrate that curcumin-mediated ER stress may account, at least in part, for the cell death of BCPAP cells.

![Curcumin induces ER expansion in BCPAP cells. (A) Curcumin enlarges ER size in BCPAP cells. After treatment with different doses of curcumin (12.5--50 μM), the ER size of BCPAP cells was measured by flow cytometry analysis using the ER-Tracker dyes. (B) ER stress inhibitor, 4-PBA, partially reverses the ER expansion induced by curcumin in BCPAP cells. Cells were pretreated with or without 2.5 mM of 4-PBA for 1 hour, followed by exposure to 50 μM of curcumin for another 24 hours. The degree of ER expansion was detected by flow cytometry. (C) 4-PBA ameliorates the cell death induced by curcumin. BCPAP cells were pretreated with or without 10 mM of 4-PBA for 1 hour before incubation with 50 μM of curcumin for another 24 hours. Representative images of Hoechst/PI staining were shown and white arrows indicated PI-positive cells. Scale bar, 10 μm. The cell death rate is expressed as percentage of PI-positive staining cells. All data shown represent the means ± S.D. of 3 independent experiments. SC = solvent control. ∗*P* \< .05, ∗∗*P* \< .01.](medi-97-e11095-g003){#F2}

3.4. Curcumin increases phosphorylation of IRE1α and XBP1 mRNA splicing in BCPAP cells
--------------------------------------------------------------------------------------

ER stress triggers the UPR to recover ER function. However, a failure to adapt to ER stress results in apoptosis. UPR is orchestrated by 3 principal branches, including PERK, IRE1α, and ATF6. Recent studies indicate that hyperactivation of IRE1α branch was shown to cause cell death^\[[@R19]\]^ and XBP-1, the downstream effector of IRE1α signaling, is required for ER membrane expansion.^\[[@R20]\]^ As shown in Fig. [3](#F3){ref-type="fig"}A, the phosphorylation of IRE1α in BCPAP cells was dose-dependently enhanced by curcumin treatment without affecting the total IRE1α protein level. Curcumin treatment, most obviously at 50 μM, induced ER stress through IRE1α signaling, which resulted in activation of the RNase domain of IRE1α and removal of a 26-nt sequence from *XBP-1u*, producing mature *XBP-1s* mRNA (Fig. [3](#F3){ref-type="fig"}B). This, in turn, activated a translational frame-shift to generate XBP-1s, a potent transcription factor (Fig. [3](#F3){ref-type="fig"}C). XBP-1s subsequently binds to promoters of several genes responsible for ER-associated degradation of misfolded glycoproteins, such as *ERdj3/DNAJB11* (DnaJ heat shock protein family member B11), ER degradation-enhancing mannosidase-like protein 1 (*EDEM1*) and stress-associated endoplasmic reticulum protein 1 (*SERP1*). RT-PCR analysis showed that the mRNA expression of *ERDJ3* and *EDEM1* increased significantly in BCPAP cells treated with 50 μM of curcumin. Whereas, among these ER chaperones, *SERP1* is more susceptible to curcumin treatment as evidenced by the significant elevation of *SERP1* mRNA expressions at all dose levels in BCPAP cells (Fig. [3](#F3){ref-type="fig"}D). Note that pretreatment with 4-PBA, a chemical chaperone, was unable to rescue the *XBP-1* mRNA splicing induced by curcumin (Fig. [3](#F3){ref-type="fig"}E), indicating that IRE-1-mediated *XBP-1* splicing is not readily reversible. These results indicate that curcumin activates the IRE1α pathway which leads to the splicing of *XBP-1* mRNA in BCPAP cells.

![Curcumin induces phosphorylation of IRE1α and *XBP-1* mRNA splicing. BCPAP cells were exposed to different dosages (12.5--50 μM) of curcumin for 24 hours. After the cells were collected, western blot or RT-PCR analysis were performed. (A) Curcumin increases the phosphorylation of IRE1α in BCPAP cells. The protein levels of phosphorylated IRE1α and total IRE1α were detected by western blot analysis. β-actin was used as a loading control. (B) Curcumin increases *XBP-1* splicing in BCPAP cells. The mRNA levels of spliced and unspliced forms of *XBP-1* were assessed by RT-PCR. *Actin* was performed as a loading control. (C) Curcumin treatment results in the conversion of inactive unspliced XBP-1 (XBP-1u) protein to an active spliced (XBP-1s) protein in BCPAP cells. The protein levels of spliced and unspliced forms of XBP-1 were detected by western blot assay. (D) Curcumin enhances the mRNA expressions of *XBP-1* downstream genes. BCPAP cells were exposed to different dosages (12.5--50 μM) of curcumin for 24 hours. The mRNA expressions of *ERDJ3*, *EDEM1*, and *SERP1* were determined by RT-PCR and normalized to that of *Actin*. The data shown represent the means ± S.D. of 3 independent experiments. ^&&^*P* \< .01, ^\#^*P* \< .05, ∗*P* \< .05, ∗∗*P* \< .01 versus SC group. (E) 4-PBA fails to rescue the *XBP-1* splicing induced by curcumin in BCPAP cells. Cells were pretreated with or without different dosages of 4-PBA (2.5--10 mM) for 1 hour. After that, cells were treated with 50 μM of curcumin for 24 hours and *XBP-1* splicing was measured by RT-PCR. IRE1α = inositol-requiring enzyme 1α, RT-PCR = reverse transcriptase-polymerase chain reaction.](medi-97-e11095-g004){#F3}

3.5. Curcumin activates the ATF-CHOP pathway leading to upregulation of pro-apoptotic CHOP expression in BCPAP cells
--------------------------------------------------------------------------------------------------------------------

ATF6 has been characterized as another important ER sensor. ER stress activation induces cleavage of the ER stress-regulated transcription factor p90 ATF6 into an active p50 form, which depends on a calcium-dependent serine protease S1P in association with S2P located in the Golgi apparatus.^\[[@R21]\]^ As illustrated in Fig. [4](#F4){ref-type="fig"}A, after treatment with curcumin, the p90 ATF6 band was markedly reduced, with a concomitant dose-dependent increase in the p50 ATF6 component. The cleaved soluble transcription factor p50 ATF6 is then free to translocate to the nucleus where it subsequently activates ER stress-responsive genes, such as *GRP78*, *GRP94*, *calreticulin*, and *CHOP*.^\[[@R22]\]^ These genes determine the outcome (survival or apoptosis) of the stress response. CHOP is a major pro-apoptotic transcription factor that mediates ER-stress induced apoptosis.^\[[@R23]\]^ RT-PCR assay revealed that curcumin increased the *CHOP* mRNA expression of BCPAP cells in a dose-dependent manner (Fig. [4](#F4){ref-type="fig"}B). Moreover, the expression of *CHOP* was markedly and significantly upregulated by curcumin treatment at 50 μM following 6, 12, and 24 hours of incubations (Fig. [4](#F4){ref-type="fig"}C). Thus, the mRNA expression of *CHOP* was enhanced by curcumin both in a dose- and time-dependent manner. Unexpectedly, curcumin treatment had no effect on the mRNA expression of *GRP78* at any indicated times. To be pointed out, the upregulation of *CHOP* mRNA induced by curcumin was abolished after pretreatment with the increasing dosage of 4-PBA. As illustrated in Fig. [4](#F4){ref-type="fig"}D, barely detectable level of *CHOP* band was observed in curcumin combined with 4-PBA at its high concentration tested (10 mM). Next, short hairpin RNAs (shRNAs) were constructed to silence the endogenous CHOP expression of BCPAP cells. Compared with the scramble shRNA, the transfection of 3 CHOP shRNA plasmids targeting different regions of human *CHOP* mRNA into BCPAP cells profoundly downregulated the levels of CHOP proteins as determined by western blotting (Fig. [4](#F4){ref-type="fig"}E). As shown in Fig. [4](#F4){ref-type="fig"}F, curcumin significantly decreased cell viability in scramble-transfected BCPAP cells, but the inhibitory effect of curcumin in cell growth was partly reversed in CHOP-knockdown cells. Taken together, these results show that curcumin triggers ER stress through activation of ATF-CHOP pathway in BCPAP cells.

![Curcumin elevates ATF6 cleavage and *CHOP* mRNA expression. (A) Curcumin induces the cleavage of ATF6 in BCPAP cells. Cells were treated with different dosages (12.5--50 μM) of curcumin for 24 hours and the uncleaved (90 kDa) and cleaved (50 kDa) forms of ATF6 were detected by western blot assay. (B) Curcumin dose-dependently increases the *CHOP* mRNA expression of BCPAP cells. BCPAP cells were exposed to different dosages (12.5--50 μM) of curcumin for 24 hours and subjected to RT-PCR analysis. (C) Curcumin increases the *CHOP* mRNA expression of BCPAP cells in a time-dependent manner. BCPAP cells were treated with 50 μM of curcumin for indicated times. Total RNAs were isolated and subjected to RT-PCR. *CHOP* and *GRP78* mRNA expression were determined and normalized to that of *Actin*. (D) 4-PBA reverses the upregulation of *CHOP* mRNA induced by curcumin. BCPAP cells were pretreated with or without different dosages (2.5--10 μM) of 4-PBA before 50 μM of curcumin exposure for additional 24 hours. *CHOP* mRNA expression was detected by RT-PCR. All data shown represent the means ± S.D. of 3 independent experiments. ^\#^*P* \< .05 versus untreated group; ∗*P* \< .05, ∗∗*P* \< .01 versus curcumin alone-treated group. (E) BCPAP cells were transfected with 3 siRNAs targeting different region of *CHOP* mRNA (shRNA-CHOP \#1, \#2, and \#3) or negative control (Scramble). Cell lysates were collected 24 hours later and CHOP knockdown efficiency were determined by western blot. (F) BCPAP cells were transfected with shRNA-CHOP \#1, \#2, and \#3 or scramble control. After 24 hours, cells were treated with or without 50 μM of curcumin for another 24 hours. The cell survival rate was determined by MTT assay. ∗*P* \< .05, ∗∗*P* \< .01. ATF6 = activating transcription factor 6.](medi-97-e11095-g005){#F4}

3.6. Curcumin perturbs the intracellular calcium homeostasis of BCPAP cells
---------------------------------------------------------------------------

Apart from the classical UPR, it is well known that cellular calcium (Ca^2+^) signaling is another vital cellular response mechanisms to cope with ER stress.^\[[@R24]\]^ ER stress frequently results in a release of Ca^2+^ from the ER, inducing cytosolic Ca^2+^ accumulation and triggering cell death.^\[[@R25]\]^ Next, Ca^2+^ influx was measured by flow cytometry following treatment of BCPAP cells with different dosages of curcumin. As shown in Fig. [5](#F5){ref-type="fig"}A, the intracellular Ca^2+^ level in BCPAP cells significantly elevated in the presence of higher dosage of curcumin at 25 and 50 μM. However, the data in Fig. [5](#F5){ref-type="fig"}B showed that 4-PBA (2.5 mM)) pretreatment had only a negligible effect on curcumin-induced elevation of intracellular Ca^2+^ level (55.17% in curcumin treated-alone group vs 49.09% in curcumin/4-PBA combination group). BAPTA-AM is a well-known membrane permeable cytosolic Ca^2+^ chelator, which could block the interaction of calcium with calmodulin and thus prevent Ca^2+^ oscillation signals. Consistent with this point, 30-minute preincubation with 1 μM of BAPTA-AM reduced curcumin-induced Ca^2+^ influx from 52.82% to 42.18% (Fig. [5](#F5){ref-type="fig"}C). Moreover, the curcumin-mediated decrease in cell viability of BCPAP cells could also be prevented by BAPTA-AM pretreatment, further suggesting a pro-death role for cytosolic calcium in this process (Fig. [5](#F5){ref-type="fig"}D). Taken together, these results confirm that curcumin disturbs the steady-state of intracellular calcium in BCPAP cells.

![Curcumin increases the intracellular Ca^2+^ level of BCPAP cells. (A) Curcumin increases the intracellular Ca^2+^ content in BCPAP cells. After BCPAP cells were exposed to different dosages (12.5--50 μM) of curcumin for 24 hours, intracellular Ca^2+^ level was detected by flow cytometry analysis using Rhod 2-AM. (B) 4-PBA fails to rescue the increased intracellular Ca^2+^ content induced by curcumin. After treatment with 50 μM curcumin, 2.5 mM 4-PBA, or the combination of 50 μM curcumin and 2.5 mM 4-PBA, the intracellular Ca^2+^ content of BCPAP cells was determined by Flow cytometry. (C) BAPTA-AM decreases the elevated intracellular Ca^2+^ level induced by curcumin. BCPAP cells were preincubated in the presence or absence of BAPTA-AM (1 μM) for 0.5 hour followed by curcumin (50 μM) treatment for 24 hours. After incubation, the intracellular Ca^2+^ content of BCPAP cells was determined by flow cytometry. (D) BAPTA-AM protects BCPAP cells from curcumin-induced cytotoxicity. Cells were treated as in (C) and the cell viability of BCPAP cells was measured by MTT assay. All data shown represent the means ± S.D. of 3 independent experiments. ^\#^*P* \< .05 versus untreated group; ∗*P* \< .05, ∗∗*P* \< .01 versus curcumin alone-treated group.](medi-97-e11095-g006){#F5}

3.7. Curcumin promotes apoptosis by activating Ca^2+^-CaMKII-JNK signaling pathway in BCPAP cells
-------------------------------------------------------------------------------------------------

High concentrations of Ca^2+^ in ER lumen are essential for ER folding capacity. SERCA, resided in the ER membrane, acts as a Ca^2+^-ATPase that transfers Ca^2+^ from the cytosol to the lumen of the sarcoplasmic reticulum at the expense of ATP hydrolysis.^\[[@R26]\]^ It has been reported that inhibition of SERCA activity impairs ER Ca^2+^ homeostasis and causes severe ER stress.^\[[@R27]\]^ First, the effect of curcumin on the protein expression of SERCA2 was detected. As shown in Fig. [6](#F6){ref-type="fig"}A, the protein levels of SERCA2 were only slightly affected by curcumin, as there was approximate 90% of SERCA2 remained even though higher dosage of curcumin was used at 25 and 50 μM. Next, the activity of Ca^2+^-ATPase in BCPAP cells was measured after incubation with various concentrations of curcumin for 24 hours. As shown in Fig. [6](#F6){ref-type="fig"}B, curcumin significantly inhibited the activity of Ca^2+^-ATPase in a dose-dependent manner. Compared with solvent control cells possessing Ca^2+^-ATPase activity at 0.091 ± 0.011 unit/mg protein, BCPAP cells exposed to curcumin at 12.5, 25, and 50 μM showed a sharp decrease in Ca^2+^-ATPase activity, with only 0.054 ± 0.018, 0.048 ± 0.017, and 0.028 ± 0.006 unit/mg of the cells, respectively. Thus, the inhibition of SERCA2 activity by curcumin could explain, in part, the increased cytosolic Ca^2+^ in BCPAP cells. Accumulated cytosolic Ca^2+^ then binds to calmodulin and this complex subsequently initiates the autophosphorylation and activation of calcium/calmodulin-dependent protein kinase II (CaMKII).^\[[@R28]\]^ Then CaMKII in turn, can lead to activation of c-Jun N-terminal Kinase (JNK) and subsequent mitochondrial-dependent apoptosis.^\[[@R29]\]^ As expected from the data in Fig. [6](#F6){ref-type="fig"}C, there was an increase in phospho-Thr287 CaMKII at relatively high doses of curcumin loading (25 and 50 μM), consistent with the significant increased intracellular Ca^2+^ level at these 2 dosage of curcumin treatment (Fig. [5](#F5){ref-type="fig"}A). As CaMKII was upstream of JNK activation, curcumin treatment was also associated with an increase in the phosphorylation of JNK (Fig. [6](#F6){ref-type="fig"}D). SP600125, an anthrapyrazolone inhibitor of JNK was also used. As shown in Fig. [6](#F6){ref-type="fig"}E and F, pretreatment with 10 μM of SP60012510 inhibited curcumin-induced phosphorylation of JNK and decreased the cytotoxicity of curcumin. Furthermore, to characterize the apoptotic process, the expressions of apoptosis-related proteins were examined by western blotting. As illustrated in Fig. [6](#F6){ref-type="fig"}G, curcumin treatment led to a dose-dependent increased expression of pro-apoptotic Bax with a concomitant decrease in the level of anti-apoptotic proteins Bcl-X~L~, Bcl-2, and Bid. In addition, curcumin treatment induced the cleavage of caspase-3, -7, and -8 (Fig. [6](#F6){ref-type="fig"}H), as well as the proteolysis of poly ADP-ribose polymerase (PARP) (Fig. [6](#F6){ref-type="fig"}I). Collectively, these results demonstrate that curcumin promotes apoptosis by activating Ca^2+^-CaMKII-JNK pathway in BCPAP cells.

![Curcumin promotes apoptosis by activating Ca^2+^-CaMKII-JNK pathway. (A) Curcumin slightly decreases the protein level of SERCA2 in BCPAP cells. BCPAP cells were exposed to different dosages (12.5--50 μM) of curcumin for 24 hours and the protein level of SERCA2 was detected by western blotting. β-actin was used as a loading control. Relative protein levels of SERCA2 were shown at the bottom of the graph. (B) Curcumin inhibits SERCA2 activity of BCPAP cells. Cells were incubated with various concentrations of curcumin for 24 hours. Then the cells were harvested and the Ca^2+^-ATPase activity was measured according to the instructions of the Ca^2+^-ATPase detection kit. Error bars are means ± S.D. of 3 independent experiments. ∗*P* \< .05, ∗∗*P* \< .01 versus SC group. (C) Curcumin treatment increases the phosphorylation of CaMKII in BCPAP cells. (D) Curcumin increases the phosphorylation of JNK of BCPAP cells. (E) BCPAP cells were either treated with 50 μM of curcumin for 24 hours or pre-treated with 10 μM of SP600125 for 1 hour before curcumin treatment. The phosphorylated and total JNK protein levels were detected by western blot assay. β-actin was used as a loading control. (F) BCPAP cells were treated as in (E). MTT assay was used to determine the cell viability. ^\#\#^*P* \< .01 versus untreated group; ∗∗*P* \< .01 versus curcumin alone-treated group. (G) Curcumin induces apoptosis of BCPAP cells. BCPAP cells were treated with curcumin at different dosages for 24 hours and then harvested for apoptosis analysis. The pro-apoptotic protein Bax and anti-apoptotic protein Bcl-X~L~, Bcl2, Bid were measured by western blotting. (H) Curcumin activates caspase-3, -7, and -8 pathway in BCPAP cells. (I) Curcumin treatment leads to an increased cleavage of PARP. These apoptosis-related proteins were determined at least 3 times and representative data were shown. PARP = poly ADP-ribose polymerase; SC = solvent control.](medi-97-e11095-g007){#F6}

4. Discussion
=============

Curcumin, derived from the rhizome of *Curcuma longa L.*, has been reported to exhibit therapeutic efficacy in patients with several types of progressive advanced cancers.^\[[@R30]\]^ Several phase I and phase II clinical trials indicate that curcumin is clinically safe and tolerable.^\[[@R31]\]^ Recent studies from our group have also proved that curcumin inhibits metastasis^\[[@R32]\]^ and induces ROS-independent DNA damage in thyroid cancer cells,^\[[@R33]\]^ indicating a potential anti-cancer ability of curcumin against thyroid cancer. In the present study, we found curcumin significantly inhibited anchorage-independent cell growth and induced apoptosis in BCPAP cells, a popularly used human papillary thyroid cancer cell line (Fig. [1](#F1){ref-type="fig"}).

ER is a major organelle for synthesis, maturation, and folding proteins. To some extent, the cell\'s fate is decided by the balance between survival and apoptotic signaling, and the specific ER stressor plays a crucial role in tuning cell homeostasis.^\[[@R17]\]^ Aimed to balance the extracellular stimulation, unfolded protein response (UPR) is activated to reduces unfolded/misfolded protein loads, however, prolonged ER stress initiates the apoptotic cell death which may dependent or independent of mitochondrial signaling.^\[[@R34]\]^ UPR is triggered in cells when ER transmembrane protein sensors (PERK, IRE, and ATF6) detect the accumulation of unfolded proteins. It has been reported that each components of UPR sensors exert fundamental roles in ER-mediated cell death.^\[[@R17]\]^ In the case of IRE1, its endoribonuclease activity catalyzes the unconventional splicing of the mRNA encoding XBP1, which induces genes related to protein folding. In addition, IRE1 can recruit TNF receptor-associated factor 2 (TRAF2), apoptosis-signal-regulating kinase (ASK1), and caspase-12 to target the activation of c-jun N-terminal kinase (JNK), which is known as a pro-apoptotic factor.^\[[@R35]\]^ Activation of the transcription factor, ATF6, and its downstream targets, that is, CHOP, has also been demonstrated as a regulator of ER-associated cell survival or death.^\[[@R36]\]^ Indeed, CHOP plays a pro-apoptotic role and is the most well recognized indicator of ER stress-induced apoptosis. It has been reported that CHOP suppressed the expression of anti-apoptotic Bcl-2 to upregulate the ratio of Bax/Bcl-2 and it also can be upregulated by TRAIL receptors to promote the cellular apoptotic pathway.^\[[@R37]\]^ In the present study, curcumin triggered ER stress in BCPAP cells as evidenced by the expansion of ER membrane (Fig. [2](#F2){ref-type="fig"}). Moreover, curcumin significantly increased the key components of the UPR pathway via phosphorylation of IRE1α, *XBP-1* mRNA splicing (Fig. [3](#F3){ref-type="fig"}) as well as activation of ATF6 and CHOP expression (Fig. [4](#F4){ref-type="fig"}).

ER participates in the initiation of apoptosis by at least 2 different mechanisms. One is the classical UPR, the other is the cellular Ca^2+^ signaling. Intracellular Ca^2+^ signals mediate various cellular processes, including mitochondrial homeostasis, cell survival, and cell death.^\[[@R38]\]^ ER is a critical reservoir of Ca^2+^ and depletion of the ER Ca^2+^ store inhibits proliferation and induces cell death in transformed cells.^\[[@R27]\]^ SERCA and inositol trisphosphate receptors (IP~3~Rs), which located on the ER membrane, regulate the Ca^2+^ flux by pumping Ca^2+^ from cytosol and releasing Ca^2+^ from ER, respectively.^\[[@R39]\]^ SERCA has 3 subfamily members (SERCA1, SERCA2, and SERCA3) and their relative expression is cell type-specific. SERCA2 is one of the family members and its aberrant increase in the expression level has been observed in certain cancers than in normal tissues. For example, it has been reported that *SERCA2* mRNA is overexpressed in ovarian cancer.^\[[@R40]\]^ In another case, the overexpression of *SERCA2* mRNA was detected in 90% of human colorectal cancer tissues.^\[[@R41]\]^ These studies suggest a possible role of SERCA2 in the development and progression of human cancers and SERCA may be a novel therapeutic target in cancer treatment. Consistent with the previous study that curcumin inhibits SERCA activity in various cell types through binding with SERCA and subsequent inhibition of its structural transformation,^\[[@R42]\]^ the activity of SERCA2 was dose-dependently suppressed by curcumin in BCPAP cells (Fig. [6](#F6){ref-type="fig"}). Accordingly, curcumin depleted ER Ca^2+^ and increased intracellular Ca^2+^ levels, and Ca^2+^ chelator BAPTA-AM partially reversed curcumin-induced ER stress and growth inhibition (Fig. [5](#F5){ref-type="fig"}). Further investigation should be focused on the possibility of SERCA2 as one of the targets in the therapy of human thyroid cancers.

The cytotoxic effects of Ca^2+^ released from the ER are mediated through accumulation in mitochondria (mitochondrial Ca^2+^ overload), which results in permeability transition and activation of apoptotic pathways.^\[[@R43]\]^ Cytosolic Ca^2+^ resulting from ER stress induces expression of the Fas death receptor through a pathway involving Ca^2+^/CaMKII and JNK. Remarkably, CaMKII serves as a unifying link between ER stress and the mitochondrial-dependent apoptotic pathway by promotion of mitochondrial calcium uptake.^\[[@R29]\]^ Consistent with this view, under Ca^2+^ influx stimulation, curcumin induced the activation of CaMKII which phosphorylated JNK, resulting in the activation of Bcl-2 family members and the cleavage of caspase and PARP (Fig. [6](#F6){ref-type="fig"}). Based on these data, we conclude that curcumin-induced disruption of Ca^2+^ homeostasis is involved in its induction of apoptosis in thyroid cancer cells.

Previous reports have indicated that a major signaling interaction in oncogenic transformation is that between Ras and Ca^2+^. Pierro et al^\[[@R44]\]^ have reported that suppression of Ca^2+^ flux to the mitochondria is a common response to K-Ras^G13D^ in colorectal cell lines and that this contributes to a survival advantage during oncogenic transformation. Activating H-, K-, and N-*ras* mutations represent the most common type of abnormality of a dominant oncogene in human cancer and mutations in all 3 *ras* genes were found both in the benign (micro-) follicular thyroid adenomas and in the follicular and undifferentiated thyroid carcinomas.^\[[@R45]\]^ Activated *ras* oncogenes has been found in approximately 80% of follicular tumors but only 20% of papillary thyroid tumors. However, both follicular and papillary carcinomas may progress to undifferentiated thyroid carcinomas.^\[[@R46]\]^ Whether the presence of the oncogenic Ras mutants also modified Ca^2+^ signals in thyroid cancer cell lines, especially in follicular thyroid carcinoma cell lines FTC-133, remains to be investigated. In our present study, we have not monitored the extent of mitochondrial Ca^2+^ uptake during the increase in cytosolic Ca^2+^ upon curcumin treatment. Given the enhancement in curcumin-mediated Ca^2+^ signaling observed in BCPAP cells, we hypothesized that mitochondrial Ca^2+^ uptake would also be enhanced and contribute to greater sensitivity to death-inducing stimuli, such as radioiodine application or chemotherapeutic drugs treatment, in thyroid cancer cells.

In summary, when BCPAP cells are exposed to curcumin, SERCA2 activity is inhibited, impairing ER Ca^2+^ homeostasis, which disturbs ER folding capacity and increases unfolded and misfolded proteins, activating the signaling pathways of UPR response and causing ER stress-associated apoptosis. Our results provoked that the Ca^2+^-dependent cell death was induced upon curcumin treatment, which may be a promising therapeutic target for thyroid cancer treatment.
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